Feasibility, Acceptability, and Preliminary Effects of ISTDP for Personality Disorders in a Specialized Psychiatric Clinic
A Pilotstudy Investigating Feasability, Acceptability and Preliminary Effects of ISTDP (Intensive Short Term Dynamic Psychotherapy) for Patients with Personality Disorder in a Psychiatric Clinic Specialized on Depression, Anxiety and PTSD
1 other identifier
interventional
34
1 country
1
Brief Summary
The primary objective of this study is to evaluate the feasibility and acceptability of a 25-week combined group and individual therapy program using Intensive Short-Term Dynamic Psychotherapy (ISTDP) for patients diagnosed with personality disorders. The secondary objective is to investigate preliminary effects of the treatment in terms of reducing symtoms of depression, anxiety and emotion regulation difficulties.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2024
CompletedStudy Start
First participant enrolled
September 9, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
September 19, 2024
September 1, 2024
3.3 years
September 8, 2024
September 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Patients experience of, and satisfaction with, the treatment assessed through qualitative interviews
Patients experience of, and satisfaction with, the treatment assessed through qualitative interviews
Immediately after treatment completion
Depression symtoms
Depression symtoms will be measured with Patient Health Questionnaire (PHQ-9; (Kroenke et al., 2001)
Baseline, weekly throughout treatment, immediately after treatment completion and 6-month follow-up
Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)
Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)
Immediately after treatment completion (25 weeks)
Adverse events related to the treatment
Adverse events related to the treatment
From start of treatment up to. 6 month follow up.
Number of individual sessions attended during the treatment
Number of individual sessions attended during the treatment
Throughout the treatment period, up to 25 weeks
Number of group sessions attended during the treatment
Number of group sessions attended during the treatment
Throughout the treatment period, up to 25 weeks
Number of dropouts
Number of dropouts
Throughout the treatment period, up to 25 weeks
Total number of sessions attended during the treatment
Total number of sessions attended during the treatment
Throughout the treatment period, up to 25 weeks
Secondary Outcomes (10)
Fear of negative emotions
Change from baseline to post-treatment (25 weeks) and follow up 6 months after treatment.
Anxiety symtoms
Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.
Emotions regulation difficulties
Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.
Severity of personality disorder
Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.
Symtoms of Borderline Personality disorder
Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.
- +5 more secondary outcomes
Study Arms (1)
ISTDP
EXPERIMENTALISTDP combined group- and individual therapy
Interventions
Both the individual therapy and the group therapy is based on ISTDP (Intensive Short-Term Dynamic Psychotherapy), an affect-focused psychodynamic therapy method. The therapy focus on the relationship between feelings, anxiety and dysfunctional emotion regulation (i.e. defenses). The purpose is to increase the capacity of anxiety regulation in the patient and to help the patient identify the dysfunctional patterns developed to avoid internal stress and then gradually approach previously warded of feelings. The individual therapy consists of 25 weekly sessions. The group treatment consists of 18 weekly sessions and is structured in three phases. Phase one: Psychoeducation about anxiety and exercises in anxiety regulation. Phase two: patients takes turn to observe their own anxiety and defenses together with a therapist. Phase three: Every session two patients will work with a chosen problem and identify defenses, anxiety and feelings together with a therapist in front of the group.
Eligibility Criteria
You may qualify if:
- Personality disorder diagnosis (Clinical assessment using STIP-5) Speaks Swedish fluently
You may not qualify if:
- Autism or intellectual disability Borderline, antisocial or narcissistic personality disorder diagnosis Need for interpreter Urgent social misery Psychotic disorder High suicidality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Region Stockholmcollaborator
- Stockholm Universitycollaborator
Study Sites (1)
Affektiva, ångest och traumaprogrammet, Psykiatri Sydväst
Stockholm, 14157, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD and licensed psychologist
Study Record Dates
First Submitted
September 8, 2024
First Posted
September 19, 2024
Study Start
September 9, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
The raw data collected in the study can be made available on a group level given that the request comply with Swedish and EU laws regulating protection of identifiable data.